| A randomized, double-blind, placebo-controlled parallel group study to assess the safety and efficacy of a new oral formulation of 2-propyl pentanoic acid (2-PPA, PEAC minitablets) for the treatment of colorectal polyps in patients with familial adenomatous polyposis (FAP) | A randomized, double-blind, placebo-controlled parallel group study to assess the safety and efficacy of a new oral formulation of 2-propyl pentanoic acid (2-PPA, PEAC minitablets) for the treatment of colorectal polyps in patients with familial adenomatous polyposis (FAP) | EUCTR2006-001886-40-DK |
